tobacco control

<p>📑 Overview This report covers Parliamentary Questions (PQs) and Commission Answers published between 03.05.2026 and 10.05.2026. During this period, 6 new PQs were published and 12 Commission Answers became available. Key themes this week included medical supply chain resilience, cancer prevention, regulation of novel health products, and health data governance. 🧬 Medicines & Regulation ❗ […]</p>

Overview This report covers Parliamentary Questions (PQs) and Commission Answers published between Monday 26.01.2026 and Sunday 01.02.2026. During this period, 15 new PQs were published and 19 Commission Answers became available. Key themes this week included health systems resilience, particularly in Greece and Italy; medicines regulation, covering vaccine safety, drug standards, and new therapies; and […]

Overview This report covers Parliamentary Questions (PQs) and Commission Answers published between Monday, 19 January 2026 and Sunday, 25 January 2026. During this period, 9 new PQs were published and 21 Commission Answers became available. Key themes this week included medicines safety and regulation, particularly concerning COVID-19 vaccines; environmental health risks from chemicals like PFAS, […]

Overview This report covers Parliamentary Questions (PQs) and Commission Answers published between Monday, 5 January 2026 and Sunday, 11 January 2026. During this period, 19 new PQs were published and 8 Commission Answers became available. Key themes this week included environmental health risks, particularly concerning PFAS and other chemical substances, water quality, and waste management. […]

📊 Medicine Shortages, Tobacco Control & Mercosur Food Safety in Focus This report summarizes key developments in EU health policy during Q4 2025, covering the period from 6 October 2025 to 28 December 2025. Over these three months, a total of 122 new Parliamentary Questions (PQs) were published and 132 Commission Answers were made available, […]

This week's EU health policy: Debates on medicines regulation, public health prevention, health systems resilience, and the health impact of external policies.

This week’s EU health policy developments: cross-border healthcare, regulation of medicines and pesticides, and oversight of national recovery funds.

This week’s EU health policy developments: regulation and transparency for medicines; prevention for public health; safety for food and chemicals

This week’s EU health policy developments span youth mental health, medical device and chemical regulation, and environmental health — with new Commission answers on Lyme diagnostics, ethanol classification, and EU-US tariff exemptions for pharmaceuticals.

This week’s EU health policy developments range from cancer prevention and tobacco control to medical device reform, pesticide regulation, and healthcare workforce resilience. The Commission confirmed plans to revise the Medical Devices Regulation by end-2025, detailed actions on e-cigarettes and vector-borne diseases, and addressed chemical safety, cross-border health risks, and emergency access in an evolving digital and environmental landscape.